Intervenções Nutricionais no Tratamento da Caquexia Oncológica: uma revisão de literatura
DOI:
https://doi.org/10.55892/jrg.v8i18.1891Palavras-chave:
Caquexia, Câncer, Intervenção nutricional, Qualidade de vida, Estado nutricionalResumo
Objetivo: A caquexia oncológica é uma condição debilitante associada ao câncer, caracterizada por perda de peso, massa muscular e distúrbios metabólicos, impactando negativamente a qualidade de vida dos pacientes. Esta revisão sistemática teve como objetivo analisar as intervenções nutricionais no manejo da caquexia oncológica, com foco na suplementação com ácidos graxos ômega-3, dietas especializadas e aconselhamento nutricional. Metodologia: Trata-se de revisão de literatura, direcionada por princípios de documentação e critérios de inclusão/exclusão propostos pelo PRISMA. A pergunta de pesquisa foi elaborada com base no modelo PICO e foram selecionados estudos clínicos e observacionais publicados nos últimos 15 anos nas bases de dados PubMed, Scopus e Cochrane Library. Os dados foram exportados para o software “Mendeley” a fim de auxiliar na seleção dos estudos. Resultados: A análise revelou que a suplementação com ômega-3 contribui para a estabilização do peso corporal e redução da inflamação sistêmica, embora não tenha mostrado impacto significativo na reversão da caquexia.
Downloads
Referências
ARENDS, J. et al. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines. ESMO Open, v. 6, n. 3, 1 jun. 2021.
BAGHERI, A. et al. The Effect of Mediterranean Diet on Body Composition, Inflammatory Factors, and Nutritional Status in Patients with Cachexia Induced by Colorectal Cancer: A Randomized Clinical Trial. Integrative Cancer Therapies, v. 22, 1 jan. 2023.
BOSSI, P. et al. The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: A narrative review. Nutrients MDPI AG, , 1 jun. 2021.
CEDERHOLM, T. et al. GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. Clinical Nutrition, v. 38, n. 1, p. 1–9, 1 fev. 2019.
COSS, C. C.; BOHL, C. E.; DALTON, J. T. Cancer cachexia therapy: A key weapon in the fight against cancer. Current Opinion in Clinical Nutrition and Metabolic Care, v. 14, n. 3, p. 268–273, maio 2011.
FEARON, K. et al. Definition and classification of cancer cachexia: an international consensus. The Lancet Oncology, v. 12, n. 5, p. 489–95, 2011.
FEARON, K.; ARENDS, J.; BARACOS, V. Understanding the mechanisms and treatment options in cancer cachexia. Nature Reviews Clinical Oncology, fev. 2013.
FEARON, K. C. H.; GLASS, D. J.; GUTTRIDGE, D. C. Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell Metabolism, 8 ago. 2012.
HAN, J. et al. Imaging modalities for diagnosis and monitoring of cancer cachexia. EJNMMI Research Springer Science and Business Media Deutschland GmbH, , 2021.
KONDRUP, J. et al. Nutritional risk screening (NRS 2002): A new method based on an analysis of controlled clinical trials. Clinical NutritionChurchill Livingstone, 2003.
LAVIANO, A. et al. Safety and Tolerability of Targeted Medical Nutrition for Cachexia in Non-Small-Cell Lung Cancer: A Randomized, Double-Blind, Controlled Pilot Trial. Nutrition and Cancer, v. 72, n. 3, p. 439–450, 2 abr. 2020.
MARTIN, L. et al. Diagnostic criteria for the classification of cancer-associated weight loss. Journal of Clinical Oncology, v. 33, n. 1, p. 90–99, 1 jan. 2015.
PRADO, C. M.; PURCELL, S. A.; LAVIANO, A. Nutrition interventions to treat low muscle mass in cancer. Journal of Cachexia, Sarcopenia and MuscleWiley Blackwell, , 1 abr. 2020.
ROELAND, E. J. et al. Management of Cancer Cachexia: ASCO Guideline J Clin Oncol. [s.l: s.n.]. Disponível em: .
SZEFEL, J. et al. L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia. Oncology Reports, v. 28, n. 1, p. 319–323, jul. 2012.
THAIR, S. A. et al. A Single Nucleotide Polymorphism in NF-κB Inducing Kinase Is Associated with Mortality in Septic Shock. The Journal of Immunology, v. 186, n. 4, p. 2321–2328, 15 fev. 2011.
THEOLOGIDES, A. CANCER CACHEXIA is characterized clinic. Cancer, v. 43, 1979.
USTER, A. et al. Influence of a nutritional intervention on dietary intake and quality of life in cancer patients: A randomized controlled trial. Nutrition, v. 29, n. 11–12, p. 1342–1349, nov. 2013.
VIGANO, A. A. L. et al. Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients. Clinical Nutrition, v. 36, n. 5, p. 1378–1390, 1 out. 2017.
WERNER, K. et al. Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial. Lipids in Health and Disease, v. 16, n. 1, 2 jun. 2017.
YU, J. et al. Effect of preoperative immunonutrition on postoperative short-term clinical outcomes in patients with gastric cancer cachexia: a prospective randomized controlled trial. World Journal of Surgical Oncology, v. 22, n. 1, 1 dez. 2024.
Downloads
Publicado
Como Citar
Edição
Seção
ARK
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
